Acuson (ACN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Acuson (ACN)

ACN 248.44

-0.7%

Nov 3 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Fisher who wrote (46)	12/28/1997 6:56:00 PM
From: Liatris Spicata	Read Replies (1) of 55

Jim- Hope you make your goal, but don't bet the farm on it. on 12 Dec. 1997 Value Line (VL) printed their quarterly rating of ACN. VL said investors seem worried about ACN's abilty to compete. Although the 3Q earnings met expections, it took a lower than expected tax rate to achieve this. Sales fell below consensus estimates. ACN indicated ts Dec. period net may be $0.17- $0.22, below recent consensus estimates of $0.25. VL thinks ACN will be able to hold its own in the ultrasound race. For example, ACN recently replaced HP as Kaiser's sole source for cardiology u/s products. VL says ACN shares have good appreciation potential, but they would wait until the current period's results are in before buying. VL had a positive assessment of ACN's new prodcuts, and they maintained the 3 rating for both Timeliness and Safety. Does anyone have a breakdown of ACN's sales in Asia? I'll go way out on a limb and say that anyone counting on big sales to Korea in '98 is going to be disappointed. Larry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next